Conversely, HER2-positive and luminal subtypes showed higher ypN0 proportions in univariable analyses but did not retain independent significance once metabolic response, pre-NAST tumor-to-axilla SUVmax ratio, and residual breast tumor size were included, suggesting that much of their favorable behavior is mediated through these response-related variables. Here, ERBB2 is linked to breast neoplasm.